CDEK by Data4ThePeople

Sign in Sign up

← All organizations

Symbion Research International

For profitWebsite ↗

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Dec 1, 2005

Timeline

1990s

Jun 1, 1995
Symbion Research International— Founded

Drugs by trial phase (1 distinct, 1 trials)

Phase 2 (1 own, 0 via acquisition)

talimogene laherparepvec

Indications

Studied for

Melanoma

Recent trials (1)

NCT00289016CollaboratorPhase 2Dec 1, 2005

Details

Founded: Newbury Park, CA, US Jun 1, 1995
Last known activity: Dec 1, 2005

Notes

CRO